Andrew J. Arakaki is a doctoral student in the Department of Chronic Disease Epidemiology at the Yale School of Public Health. His research is focused on assessing the impact of everyday discrimination on patient-reported outcomes, outpatient care utilization, and biomarkers of systemic inflammation among young adults with acute myocardial infarction. Andrew completed his MPH at the Yale School of Public Health in 2020 and conducted research at the Yale Center for Outcomes Research and Evaluation (CORE) using data from the National Cardiovascular Disease Registry (NCDR). He also holds a Bachelor of Science degree in Biology from the University of Washington.
2022 Awardees
- Tiffany E. Chang is a PhD Candidate in the Department of Chronic Disease Epidemiology at Yale School of Public Health. Her dissertation research examines the sex-specific impact of patient- and system-level factors on hypertension outcomes among young Veterans. Prior to her doctoral studies, Tiffany worked as a health services researcher (contractor) at the Centers for Disease Control and Prevention, as well as a quality improvement director at the American Heart Association. Tiffany earned her MPH from Yale School of Public Health and her BA from Cornell University.
- Rebecca is a PhD candidate in the Grubaugh Lab in the Department of Epidemiology of Microbial Diseases. Her research focuses on the outbreak dynamics of emerging viruses in human and animal populations. Previously, Rebecca was a Research Analyst in the Prevention Policy Modeling Lab at the Harvard T.H. Chan School of Public Health, where her work focused on modeling the potential impact of changes in disease control strategies. She received a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health, and also has four years of experience in global and domestic health consulting.
- Kelly is a PhD student in the Department of Epidemiology of Microbial Diseases. Her research interests focus on reducing vector-borne and zoonotic diseases in low income countries by identifying social, biological, and environmental risk factors of disease. Specifically, she hope to use molecular epidemiological studies to gain insight into pathogenesis and to improve the prevention and control of infectious diseases.
- Guneet is a fourth-year medical student. Prior to medical school, he got a degree in biochemistry at the Ohio State University and then engaged in structural biology research at the National Cancer Institute. His research interests include regulatory science and microbial dysgenesis in autoimmune disease. At CRIT, he is investigating the feasibility of using Real-World Data and Real-World Evidence for drug approvals.
- Katerina Santiago is a PhD student in the Department of Chronic Disease Epidemiology at Yale School of Public Health. She earned her Master of Public Health (MPH) from the University of Miami, Miller School of Medicine and her Bachelor of Science (BS) degree in Biology with Honors from the University of Miami. Prior to her doctoral studies, Katerina worked as a research associate at the University of Miami, Miller School of Medicine where her research focused on occupational exposures and their association with various health effects such as injuries and cancer and how such risks vary by race and ethnicity. Her current research interests are epidemiology of cancer, with a specific interest in gastrointestinal cancers, and how genetic risk interacts with environmental and occupational exposures.
- Sunny Siddique is a doctoral candidate in the Department of Chronic Disease Epidemiology at the Yale School of Public Health. He holds a Master of Public Health (MPH) in Epidemiology from Columbia University and a Bachelor of Arts (BA) in Molecular Biology from Princeton University. Prior to Yale, Sunny served as a Cancer Research Training Award Fellow at the National Cancer Institute where he studied age-related functional outcomes among cancer survivors, pain management among cancer patients visiting the ER, and follow-up and surveillance strategies to improve detection of cancer recurrence. Sunny has also conducted substantial work in analyzing cancer center catchment areas and identifying neighborhood level disparities in cancer treatment and outcomes. His current research interests include: risk factors and screening for early-onset gastrointestinal cancers (particularly colorectal, pancreas, stomach, and liver cancers), access and utilization of novel treatments, and the functional outcomes of long-term cancer survivors.